New heart valve offers hope for patients with severe leaky heart
NCT ID NCT07536724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new device called the TRICENTO G2 to treat severe tricuspid regurgitation, a condition where a heart valve leaks badly. Ten adults with symptoms like shortness of breath or swelling will get the valve through a minimally invasive procedure. The goal is to see if it safely improves their condition and reduces the leak.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYMPTOMATIC TRICUSPID REGURGITATION (TR) GRADED AS SEVERE OR GREATER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.